These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6684842)

  • 1. [Critical analysis of fetal risk recognition by serum estriol determination].
    Distler W; Kiwit JC
    Z Geburtshilfe Perinatol; 1983; 187(4):168-74. PubMed ID: 6684842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine assessment of high-risk pregnancies.
    Petersen LP; Kundu N
    Obstet Gynecol Annu; 1980; 9():169-94. PubMed ID: 6773003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial first morning estriol determinations in evaluating the high-risk obstetric patient.
    Seibel MM; Levesque LA; Seidenberg EJ; Ransil BJ
    Obstet Gynecol; 1982 Jan; 59(1):27-32. PubMed ID: 7078846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fetal well-being monitoring: comparison between a new method of serum estriol assaying and determination of urinary estriol/creatinine].
    Zhao YG
    Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):361-4, 388. PubMed ID: 1804609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the oxytocin challenge test on levels of maternal serum unconjugated serum estriol and estetrol pre- and post-test in high-risk pregnancies.
    Sampson MB; Kundu N; Peterson LP
    Am J Perinatol; 1986 Jan; 3(1):22-3. PubMed ID: 3942609
    [No Abstract]   [Full Text] [Related]  

  • 6. Maternal serum unconjugated estriol and urine estriol concentrations in normal and high-risk pregnancy.
    Miller CA; Fetter MC; Boguslaski RC; Heiser EW
    Obstet Gynecol; 1977 Mar; 49(3):287-92. PubMed ID: 840456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prolactin in normal and pathologic pregnancy.
    Sadovsky E; Weinstein D; Ben-David M; Polishuk WZ
    Obstet Gynecol; 1977 Nov; 50(5):559-61. PubMed ID: 909661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estriol determinations in the management of high-risk pregnancies.
    Magendantz HG; Klausner D; Ryan KJ; Yen SS
    Obstet Gynecol; 1968 Nov; 32(5):610-9. PubMed ID: 5742475
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of serum unconjugated estriol and estetrol in normal and complicated pregnancies.
    Kundu N; Wachs M; Iverson GB; Petersen LP
    Obstet Gynecol; 1981 Sep; 58(3):276-81. PubMed ID: 7266946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of pregnancy at risk: evaluation of fetal movements, determination of total plasma estriol and placental lactogen hormone in relation to fetal heart rhythm].
    Mbanzulu PN; Leng JJ; Commenges D; Salamon R
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):779-84. PubMed ID: 3794214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
    Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
    J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma unconjugated estriol as an indicator of fetal dysmaturity in postterm pregnancy.
    Yeh SY; Read JA
    Obstet Gynecol; 1983 Jul; 62(1):22-5. PubMed ID: 6856218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioimmunologic determination of estriol, HPL, and alpha fetoprotein in maternal serum and their values in pregnancies at risk (proceedings)].
    Arnold P; Rauskolb R; Jovanović V; Bleyl H
    Arch Gynakol; 1977 Jul; 224(1-4):123-4. PubMed ID: 74991
    [No Abstract]   [Full Text] [Related]  

  • 14. Reliability of antenatal testing: estriol levels versus nonstress testing.
    Lauersen NH; Kurkulos M; Graves ZR; Lewin K
    Obstet Gynecol; 1983 Jul; 62(1):11-6. PubMed ID: 6856212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
    Saller DN; Canick JA; Palomaki GE; Knight GJ; Haddow JE
    Obstet Gynecol; 1994 Nov; 84(5):852-5. PubMed ID: 7524003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pregnancies of high fetal risk. II. Evolution of fetoplacental function in intrahepatic cholestasis in pregnancy by means of urinary excretion of estriol].
    Espinoza J; Barnafi L; Gormaz G; Manubens F
    Rev Chil Obstet Ginecol; 1975; 40(4):203-11. PubMed ID: 1233548
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol.
    Markestad T; Bergsjø P; Aakvaag A; Lie RT; Jacobsen G; Hoffman HJ; Bakketeig LS
    Acta Obstet Gynecol Scand Suppl; 1997; 165():50-5. PubMed ID: 9219457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles of managing the high-risk pregnant patient.
    Zoller DP
    Am Fam Physician; 1983 Jan; 27(1):216-21. PubMed ID: 6823794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal variations in unconjugated and total plasma estriol levels in late normal pregnancy.
    Compton AA; Kirkish LS; Parra J; Stoecklein S; Barclay ML; McCann DS
    Obstet Gynecol; 1979 May; 53(5):623-6. PubMed ID: 571590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.